You just read:

Actinium Presents Positive Findings from Mid-Point Analysis of Pivotal SIERRA Trial of Iomab-B at 2020 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR (TCT)

News provided by

Actinium Pharmaceuticals, Inc.

Feb 21, 2020, 07:30 ET